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Applying Classical Realism, Institutional Liberalism and Normative Theory to the
Development and Distribution of a COVID-19 Vaccine
Abstract
The development of a safe and effective Coronavirus vaccine has dominated the concerns of the
international community over the course of the last six months. While the global community agrees on
the importance of its development, it is not entirely clear how a vaccine will be distributed globally. The
implications of which entity, whether a state or private company, develops a trusted vaccine first and how
efficiently and equitably that vaccine is distributed are yet to be seen. Using Classical Realism,
Institutional Liberalism, and Normative Theory, this paper seeks to discuss and analyze how the
development of a vaccine will affect the international community. Specifically, using Classical Realism,
this paper will address the implications of a global power developing a vaccine and how nationalism will
affect that development and subsequent distribution. Secondly, through Interdependence Liberalism, this
paper will analyze the prospects of vaccine distribution among states, the role of non- governmental
organizations (NGOs) and international organizations, as well as private industry, in vaccine development.
Furthermore, through this lens this paper will analyze the interdependence of states regarding effective
global containment of the coronavirus. Lastly, this paper will employ Normative Theory to analyze the
obligation of major world powers, specifically the United States, to ensure a safe and effective vaccine is
developed efficiently and distributed equitably. Evidently, containing and eliminating the coronavirus
through a vaccine is both of paramount importance and laden with challenges. This paper aims to
determine the most predictive theory relating to how the international system will react to the
development of a coronavirus vaccine and what the implications and predicted outcomes are for the
actors which comprise the global community.
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Abstract: The development of a safe and effective Coronavirus vaccine has
dominated the concerns of the international community over the course of the
last six months. While the global community agrees on the importance of its
development, it is not entirely clear how a vaccine will be distributed globally. The
implications of which entity, whether a state or private company, develops a
trusted vaccine first and how efficiently and equitably that vaccine is distributed
are yet to be seen. Using Classical Realism, Institutional Liberalism, and
Normative Theory, this paper seeks to discuss and analyze how the development
of a vaccine will affect the international community. Specifically, using Classical
Realism, this paper will address the implications of a global power developing a
vaccine and how nationalism will affect that development and subsequent
distribution. Secondly, through Interdependence Liberalism, this paper will
analyze the prospects of vaccine distribution among states, the role of
nongovernmental organizations (NGOs) and international organizations, as well
as private industry, in vaccine development. Furthermore, through this lens this
paper will analyze the interdependence of states regarding effective global
containment of the coronavirus. Lastly, this paper will employ Normative Theory
to analyze the obligation of major world powers, specifically the United States, to
ensure a safe and effective vaccine is developed efficiently and distributed
equitably. Evidently, containing and eliminating the coronavirus through a
vaccine is both of paramount importance and laden with challenges. This paper
aims to determine the most predictive theory relating to how the international
system will react to the development of a coronavirus vaccine and what the
implications and predicted outcomes are for the actors which comprise the global
community.
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Introduction
The COVID-19 pandemic has touched the lives of every citizen in every
country around the world. The rapid spread of the virus caused sweeping
economic shutdowns, among a wide range of other dramatic shifts in everyday
life. Almost as soon as the pandemic hit, the global community began to focus its
attention on the development of a safe and effective vaccine in addition to
containing the spread. For billions of people, the development and distribution of
a vaccine signifies hope for a return to normalcy. In many wealthy, western
nations, the expectation of having access to an eventual vaccine seems to be a
foregone conclusion. However, many countries and people around the globe are
left wondering if, when and how they will receive vital access to this life saving
vaccine. Ensuring the equitable and timely distribution of a vaccine to all corners
of the globe is no small task. For that matter, neither is the development of a safe
and effective vaccine in the first place. Vaccine development is an already
complex and costly process which, in the context of COVID-19, is only
compounded by an accelerated time frame due to the immediate and widespread
need. In circumstances other than a pandemic, the development of an effective
and trusted vaccine typically consists of three phases, antigen identification and
production, nonclinical testing and clinical trials, and typically takes approximately
10-15 years (Han 2015). Now of course the global community is currently
operating under extraordinary circumstances, but the challenge of developing a
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universally trusted and effective vaccine in a year or less cannot be understated.
With so many unknowns as to how exactly this production and distribution
process will unfold, it is worth examining the critical dimensions of this issue as
they relate to the international community. Furthermore, in utilizing three
essential theories of international relations, classic realism, institutional liberalism
and normative theory, it is possible to uncover looming issues and identify the
most likely outcomes regarding the nature of the development and distribution of
a COVID-19 vaccine.

Key Dimensions
A lot of questions currently surround the production and distribution of a
COVID-19 vaccine, even as major corporations like Pfizer and Moderna release
promising results from their clinical trials. One of the primary concerns for the
international community is vaccine nationalism, which threatens to inhibit the
equitable and timely distribution of a vaccine around the world. Vaccine
nationalism implies a situation in which nations vie for first access to vaccines as
they become available. Involved with this idea of vaccine nationalism are
concerns that actions taken by specific nations will hurt the global community's
ability to effectively combat and contain the pandemic (Hafner et al. 2020). A
couple of these worrisome actions include the possibility that specific countries
gain and maintain control over the means of production for a vaccine and that a
few select countries buy up large shares of a vaccine’s doses due to their relative
wealth. By late August, the United States had already preordered approximately
800 million doses of the vaccine from 6 different producers currently engaged in
trials (Callaway 2020). The relative wealth and spending capacity of many
western nations, such as the United States and the UK certainly places them in a
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more advantageous position than other, less economically well-off nations. One
of the main reasons why vaccine nationalism is one of the primary concerns
facing the global community is that widespread and equitable distribution is
essential to effectively containing the pandemic. If a vaccine is only available to
specific nations or regions, the possibility of the international community
achieving herd immunity, which is essential to ending the pandemic, is severely
threatened (Weintraub et al. 2020). Furthermore, while not only costly in terms of
lives, vaccine nationalism also poses a significant economic threat. According to
one study, should the vaccine not be distributed in a timely and widespread
manner due to vaccine nationalism, the potential cost to the global economy is
approximately $1.2 trillion annually in terms of GDP (Hafner et al. 2020). The
reason for this significant economic threat is that if the virus is still spreading at a
rapid rate in certain regions of the world, it will still negatively impact the global
economy even if certain countries or regions have the virus under control.
An extremely important dimension pertaining to the development and
distribution of a vaccine is the essential role being played by private corporations
and non-governmental organizations (NGOs). Two companies which have been
making headlines recently, Pfizer and Moderna, are emblematic of the private
sectors essential role in vaccine production. During the beginning stages of
vaccine development in April, 56 of the 78 confirmed candidates (72%) were
represented by the private sector compared to only 22 by the public sector (Le et
al. 2020). Essentially, private sector corporations are leading the way in terms of
production. Pfizer, the American pharmaceutical company, recently released the
results of their latest phase of trials which reported that their vaccine candidate
was 95% effective in preventing COVID-19 infection (Pfizer 2020). Moderna, a
biotechnology company, also recently released the results of their latest trial
204

which showed similar efficacy rates to that of the Pfizer vaccine. With promising
results coming from the private sector, countries around the world are working,
as they have been for months, to secure the purchase of necessary doses.
Although no vaccine is currently in distribution, as of late November
approximately 6.4 billion doses of candidate vaccines have already been
purchased, with the “vast majority” of pre orders coming from high-income
countries (Cuddy 2020). Evidently, the sale of potential vaccine doses is where
the effects of vaccine nationalism are felt the most as the wealthiest countries
stand to have a significant advantage in procuring the maximum doses as soon
as possible.
NGOs, such as the World Health Organization (WHO), among others, are
working to ensure equitable distribution extends beyond high-income nations.
Beginning in April, the World Health Organization, working in conjunction with
Gavi, the Vaccine Alliance, established the “three pillars” which comprise the
Access to COVID-19 Tools (ACT). One of these pillars is COVAX, which aims to
provide equitable distribution and access to all the countries of the world,
regardless of their relative income and wealth. Essentially, COVAX is a global
access facility which aims to ensure that all countries who buy into the program
receive access to a COVID-19 vaccine. Through Official Development
Assistance (ODA), as well as private donations, COVAX aims to make it possible
for the lower-income countries to receive the benefits of a vaccine. While the
central focus of this initiative is on these less-wealthy countries, higher-income
nations also are eligible to buy in as well (Berkley 2020). In fact, as of
midOctober, 183 of the world’s countries had joined the program, with notable
exceptions being Russia and the United States. Current member countries
represent a diverse financial background comprising high and low-income
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countries alike. These current high participation rates give hope that this global
initiative will be able to effectively meet its goal of combining resources and
ensuring the distribution of 2 billion doses of a vaccine within the coming year
(Lawler 2020). Overall, the role of NGOs, primarily the WHO and their COVAX
facility, serves as the primary example of a coordinated, international effort to
ensure access to a vaccine is equitable.
Another intriguing dimension of the debate surrounding vaccine
production and distribution are the moral considerations and obligations to
ensure that all people, regardless of privilege or status, can obtain doses of an
eventual vaccine. Essentially, this aspect of the global vaccine challenge poses
the question of whether world powers and wealthy nations, like the United States,
have a moral obligation to work towards equitable vaccine distribution around the
world, not just within their own countries. As many of the international
community’s highest income nations are purchasing large shares of vaccine
doses, numerous health groups and other organizations are calling for these
same nations to dedicate a portion of their vaccine shares to a global
humanitarian effort. This proposed “humanitarian buffer” plays upon an asserted
moral obligation of the international community to ensure that vaccines will be
available to all people, including those in disadvantaged or otherwise challenging
situations such as refugees and those living in war-torn regions where effective
distribution through one government or another is unlikely (Safi 2020). This call
for the international community’s support of humanitarian efforts to provide
vaccinations for all people regardless of circumstance stands in stark contrast
with the state of global health systems prior to the onset of the pandemic.
Essentially, the global health system was, and some argue still is, “based on selfinterests and national interests rather than on principles of justice” (Ruger 2020).
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Many experts argue that this self-interest, which operated in place of a
coordinated global effort, is to blame for the rapid spread and inequitable impact
of COVID-19 around the world.

Classical Realism
Prior to discussing vaccine production and distribution through the lens of
classical realism, it is worth identifying the key aspects of this theory of
international relations. The central principles of classical realism are
characterized by self-interest, significant importance placed on power and
national security and the assumption of anarchy regarding the international
system. Furthermore, another tenet of classical liberalism outlines the assertion
that obligations to the international community are nonexistent (Eager 2020).
Through the lens of classical realism, the rise and continued prevalence of
vaccine nationalism comes as no surprise. Operating under the assumption that
national security and self-interest are paramount, the trend of countries vying to
be first in line to receive vaccines, even at the cost of disadvantage in the global
community, appears to occur in a manner predicted by classical realism.
Furthermore, under this theory, countries should do whatever possible to procure
the maximum doses of a vaccine on the most accelerated timetable possible.
This predicted global competition for a vaccine is evidenced by the rise in cyber
espionage as it relates to vaccine nationalism. In a report on the aspects of
vaccine nationalism, it was stated that cyber espionage efforts have risen
drastically, with efforts aimed at keeping tabs on other countries' progress on the
development and research of a vaccine (Fidler 2020). This development is not
shocking when examined through classical realism as one country staying
informed on the progress of other nations certainly seems to help promote their
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national security and power. One of the primary reasons why the race for a
vaccine appears to be causing conflict and fostering self-interest is that a
successful and rapidly produced and distributed vaccine represents a return to
normalcy, which involves the reopening of economies. It is not outside the realm
of possibility that countries believe that, should they have a vaccine before other
nations, their relative power would increase due to their ability to reopen their
economy before others. Another reason why countries want to be the first to
develop a vaccine is demonstrated by Russia apparently “winning” the vaccine
race. While there is currently no global consensus on the efficacy and safety of
the Russian vaccine, John Moore, a vaccine researcher at Weill Cornell Medical
College, stated of Russia that, “They want to be seen as keeping up with their
competitors in other countries. It’s clearly a rushed announcement” (Cohen
2020). This assessment of Russia’s vaccine announcement clearly demonstrates
a focus on national power, or an appearance of national power, in relation to the
rest of the international system.
In terms of the tenet of classical realism that states that international
obligations are essentially nonexistent, the expectation would be that countries
do not contribute to global vaccine distribution efforts, such as COVAX, but rather
focus entirely on procuring vaccines for their country alone. It appears, to this
point, that a couple countries are acting in accordance with this key realist
principle. Of the 183 countries that have currently committed to the COVAX
initiative, the two notable absences are the United States and Russia (Lawler
2020). Perhaps the reason behind this reluctance to join the global effort is based
on both countries' belief that they already have guaranteed sufficient doses of a
vaccine. For example, as previously stated, the United States has already
preordered millions of doses while Russia has reportedly developed a vaccine of
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their own. Regardless of their status regarding access to a vaccine, choosing not
to engage in the only real global effort to produce a vaccine that will be available
worldwide demonstrates the belief that no meaningful obligation to the
international community, at least in terms of public health, exists. While it is still
possible for these two countries to contribute to the global vaccine effort, the
reality of the situation seems to be best summed up by a quote from Peter
Marks, an official with the U.S. Food and Drug Administration, which compared
the race for a vaccine to oxygen masks in a plane by saying “You put on your
own first, then we want to help others as quickly as possible” (Bollyky and Bown
2020). In general, classical realism predicts that vaccine nationalism will persist
with individual countries placing importance on distributing vaccines to their
citizens above all other concerns.

Institutional Liberalism
The theory of institutional liberalism focuses on the effects and benefits of
international organizations and NGOs in promoting cooperation and mutual gains
from membership and involvement. In the context of the COVID-19 pandemic
and the race for a vaccine, the seemingly most important institution is the World
Health Organization (WHO), specifically its combined efforts with Gavi, the
Vaccine Alliance, in establishing the global access facility called COVAX. The
primary goal of COVAX, as discussed above, is to promote equitable allocation
of vaccines, especially for lower-income nations. In the context of institutional
liberalism, this lens would predict that nations would choose to buy into the
initiative in order to reap the benefits which their membership would provide. In
the specific case of COVAX, benefits appear to exist for both low-income and
high-income countries alike. For example, low-income countries, through
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subsidized membership, would be able to gain access to sufficient vaccine doses
that they may otherwise not be able to secure. As for high-income countries, the
director of COVAX states that the advantage of joining the program is that the
wide-ranging number of vaccine candidates essentially provides a safety net or
backup plan should they need an additional supply of vaccine doses down the
road (Berkley 2020). Under the lens of institutional liberalism, these expected
benefits should help facilitate cooperation within the international system.
Furthermore, the success of institutional initiatives like COVAX lies in the belief
that the countries of the world have shared interests in effectively containing the
virus around the globe. In general, the theory of liberalism places faith in human
rationality and the ability of humans to cooperate when necessary in order to
facilitate progress (Eager 2020). According to this tenet of liberalism, countries
choosing to engage with NGOs to accelerate efforts to distribute a vaccine
globally are placing rationality and cooperation at the forefront of their decision
making. Essentially, joining these institutional efforts constitutes the belief of
nations that the benefits of cooperation and a coordinated effort are worth the
investment and membership.

Normative Theory
In general, normative theory is primarily focused on ethical and moral
considerations concerning how countries and actors within the international
system should theoretically act in accordance with moral principles. When
considering the principles of normative theory in the context of the ongoing
pandemic and race for a vaccine, the main assertion that seems to follow moral
considerations is that the countries of the world, primarily those higher-income
countries, should work to ensure that vaccine distribution is equitable and is
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available to all persons regardless of circumstance. The reason this assertion
appears to be a reasonable moral obligation is based on the belief that a COVID19 vaccine is a global public good and should be treated as such, instead of as a
consumer product which goes to whoever is willing to pay the most. As a public
good, COVID-19 vaccines should be expected to reach every region of the globe
with relative equity and nations should not monopolize production or access.
Evidently, the concepts employed by normative theory conflict directly with the
reality of vaccine nationalism currently facing the international community. A
“three-way conflict” for access to vaccines appears to have arisen as private
industry, national interests and international organizations represent distinct
interests. For example, private industry is interested in creating a vaccine and
securing patents that allow them to turn a profit while national interests drive
countries to try to procure vaccines for themselves alone. It appears, as of now,
that the only entity aiming to provide equitable distribution of the vaccine as a
public good are international organizations (Hein and Paschke 2020).
Overall, under normative theory, certain actions would be deemed
immoral while others would be described as following moral considerations. For
example, wealthy nations who are buying extremely large portions of vaccine
supplies may be purported to be acting immorally as they have the financial
resources to both supply their own citizens with sufficient doses of a vaccine
while also aiding international efforts aimed at ensuring the vaccine reaches
every corner of the globe. While vaccine nationalism is undoubtedly present,
examples of nations acting in accordance with moral obligations are also
prevalent. For example, economically advantaged countries such as the United
Kingdom, among other nations, have contributed significantly toward the COVAX
initiative which, for the UK, constituted a $727 million donation (Akhtar 2020).
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Furthermore, other countries have engaged in acts of goodwill that seem to be
rooted in moral obligations. One of those countries is Canada who currently has
secured the most vaccine doses per capita. Since they are economically well off
and have sufficient vaccination capabilities, Canada is currently engaged in
discussions which should ultimately result in the donation of excess doses to
lower-income countries (Ljunggren et al. 2020). The example set by Canada
represents a stark contrast to the negative implications of vaccine nationalism
and demonstrates what normative theory would presumably classify as acting
according to moral principles. In conclusion, the role of moral considerations in
international health concerns can be summed up by one quote from Jennifer
Ruger which states, “Fundamentally, justice lies at the root of global health
issues” (Ruger 2020). Essentially, should countries act in a manner incongruent
with justice in terms of global health, then they are also acting in a way that does
not align with moral considerations.

Predictive Analysis
After considering the range of literature presented and assessing the
current landscape of vaccine production and projected distribution, it appears
that the theory with the greatest potential for predictive analysis is classical
realism. While all three theories hold some predictive potential, the capacity of
the principles of classical realism to both predict and shape the nature of how
vaccine production and distribution will unfold seems to outweigh that of the other
two. While NGOs and other international organizations will certainly play a role in
the eventual distribution of a vaccine to low-income countries and other
economically disadvantaged regions and people, they remain at the mercy of
high-income countries for their support and success. For example, the WHO
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relies heavily on voluntary donations from its member countries as they make up
approximately 80% of their funding. Furthermore, the United States represents
the biggest contributor to the WHO and in May announced they would be leaving
the organization (Marion 2020). Due to their reliance on voluntary donations and
funding from member countries, it will be very challenging for international efforts
to trump the effects of vaccine nationalism and self-interest. In terms of current
supply, COVAX remains well behind those economically well-off countries who
have engaged in the preordering of vaccine doses for months (Callaway 2020).
The significant influence and prevalence of vaccine nationalism signals
that the key principles of classical realism, primarily self-interest, concerns for
power and a lack of obligation to the international community, are winning out
over the central aspects of institutional liberalism and normative theory. The
current scenario facing the international community is best described by the
quote, “the global COVID-19 vaccine landscape is a patchwork of narrow
nationalist approaches and broader international initiatives” (Morrison et al.
2020). Although these international initiatives do exist, their scope and efficacy
are still yet to be seen. Some doubt has already been cast over whether COVAX
has the resources it requires to turn their goal of equitable access into reality
(Morrison et al. 2020). Furthermore, the fact that two of the international
community’s more powerful actors, the United States and Russia, have not
contributed to the effort spells trouble for the ability of the program to achieve
distribution within the same timeframe projected for those countries who have
already entered into agreements with private corporations to secure a large
supply of vaccines (Lawler 2020). Overall, classical realism outlines that
countries will place their own citizens and interests above that of the global
community and will be inclined to withhold resources in order to ensure their
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individual country is able to adequately control the spread of the virus, even if
that means allowing the pandemic to continue in other parts of the world.
Furthermore, it appears entirely possible that vaccine nationalism and the
principles of classical realism dominate until those high-income countries have
secured and distributed a vaccine in their country. Perhaps once widespread
distribution within economically advantaged countries occurs the international
community will witness an influx of resources and assistance to ensure vaccines
are eventually attainable for the entirety of the global population.
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